Recent Publications

• 1. Bawany F
  2. Northcott CA
  3. Beck LA
  4. Pigeon WR
  Sleep Disturbances and Atopic Dermatitis: Relationships, Methods for Assessment, and Therapies.; The journal of allergy and clinical immunology. In practice. 2020 Dec 12.
• 1. Bawany F
  2. Franco AI
  3. Beck LA
  Dupilumab: One therapy to treat multiple atopic diseases.; JAAD case reports; Vol 6(11). 2020 Nov.
• 1. Beck LA
  2. Silverberg JI
  3. Simpson EL
  4. Yosipovitch G
  5. Eckert L
  6. Guillemin I
  7. Chen Z
  8. Ardeleanu M
  9. Plaum S
  10. Graham N
  11. Ruddy M
  12. Pirozzi G
  13. Gadkari A
  Dupilumab Significantly Improves Sleep Outcomes in Adult Patients with Atopic Dermatitis: Results from Five Randomized Clinical Trials.; Journal of the European Academy of Dermatology and Venereology : JEADV. 2020 Aug 12.
• 1. Paller AS
  2. Siegfried EC
  3. Thaçi D
  4. Wollenberg A
  5. Cork MJ
  6. Arkwright PD
  7. Gooderham M
  8. Beck LA
  9. Boguniewicz M
  10. Sher L
  11. Weisman J
  12. O'Malley JT
  13. Patel N
  14. Hardin M
  15. Graham NMH
  16. Ruddy M
  17. Sun X
  18. Davis JD
  19. Kamal MA
  20. Khokhar FA
  21. Weinreich DM
  22. Yancopoulos GD
  23. Beazley B
  24. Bansal A
  25. Shumel B
  Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: a randomized, double-blinded, placebo-controlled phase 3 trial.; Journal of the American Academy of Dermatology. 2020 Jun 20.
• 1. Beck LA
  2. Thaçi D
  3. Deleuran M
  4. Blauvelt A
  5. Bissonnette R
  6. de Bruin-Weller M
  7. Hide M
  8. Sher L
  9. Hussain I
  10. Chen Z
  11. Khokhar FA
  12. Beazley B
  13. Ruddy M
  14. Patel N
  15. Graham NMH
  16. Ardeleanu M
  17. Shumel B
  Dupilumab Provides Favorable Safety and Sustained Efficacy for up to 3 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis.; American journal of clinical dermatology. 2020 Jun 17.
• 1. Wollenberg A
  2. Beck LA
  3. Blauvelt A
  4. Simpson EL
  5. Chen Z
  6. Chen Q
  7. Shumel B
  8. Khokhar FA
  9. Hultsch T
  10. Rizova E
  11. Rossi AB
  12. Graham NMH
  13. Pirozzi G
  14. Lu Y
  15. Ardeleanu M
  Assessing the need for routine safety testing for patients being treated with dupilumab for moderate-to-severe atopic dermatitis.; The British journal of dermatology; Vol 182(6). 2020 Jun.
• 1. Moran MC
  2. Beck LA
  3. Richardson CT
  A Spectrum of Skin Disease: How Staphylococcus aureus Colonization, Barrier Dysfunction, and Cytokines Shape the Skin.; The Journal of investigative dermatology; Vol 140(5). 2020 May.
• 1. Simpson E
  2. Bissonnette R
  3. Eichenfield LF
  4. Guttman E
  5. King B
  6. Silverberg JI
  7. Beck LA
  8. Bieber T
  9. Reich K
  10. Kabashima K
  11. Seyger M
  12. Siegfried E
  13. Stingl G
  14. Feldman SR
  15. Menter A
  16. van de Kerkhof P
  17. Yosipovitch G
  18. Paul C
  19. Martel P
  20. Dubost-Brama A
  21. Armstrong J
  22. Chavda R
  23. Frey S
  24. Joubert Y
  25. Milutinovic M
  26. Parneix A
  27. Teixeira HD
  28. Lin CY
  29. Sun L
  30. Klekotka P
  31. Nickoloff B
  32. Dutronc Y
  33. Mallbris L
  34. Janes JM
  35. DeLozier AM
  36. Nunes F
  37. Paller AS
  The validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD™): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis.; Journal of the American Academy of Dermatology. 2020 Apr 25.
• 1. Platts-Mills TAE
  2. Commins SP
  3. Biedermann T
  4. van Hage M
  5. Levin M
  6. Beck LA
  7. Diuk-Wasser M
  8. Jappe U
  9. Apostolovic D
  10. Minnicozzi M
  11. Plaut M
  12. Wilson JM
  On the cause and consequences of IgE to galactose-α-1,3-galactose: A report from the National Institute of Allergy and Infectious Diseases Workshop on Understanding IgE-Mediated Mammalian Meat Allergy.; The Journal of allergy and clinical immunology; Vol 145(4). 2020 Apr.
• 1. Wieser JK
  2. Kuehn GJ
  3. Prezzano JC
  4. Cusick EH
  5. Stiegler JD
  6. Scott GA
  7. Liesveld JL
  8. Beck LA
  Improvement in a patient with hypereosinophilic syndrome after initiation of dupilumab treatment.; JAAD case reports; Vol 6(4). 2020 Apr.
• 1. Guttman-Yassky E
  2. Thaçi D
  3. Pangan AL
  4. Hong HC
  5. Papp KA
  6. Reich K
  7. Beck LA
  8. Mohamed MF
  9. Othman AA
  10. Anderson JK
  11. Gu Y
  12. Teixeira HD
  13. Silverberg JI
  Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial.; The Journal of allergy and clinical immunology; Vol 145(3). 2020 Mar.
• 1. Bawany F
  2. Beck LA
  3. Järvinen KM
  Halting the March: Primary Prevention of Atopic Dermatitis and Food Allergies.; The journal of allergy and clinical immunology. In practice; Vol 8(3). 2020 Mar.
• 1. Simpson EL
  2. Lacour JP
  3. Spelman L
  4. Galimberti R
  5. Eichenfield LF
  6. Bissonnette R
  7. King BA
  8. Thyssen JP
  9. Silverberg JI
  10. Bieber T
  11. Kabashima K
  12. Tsunemi Y
  13. Costanzo A
  14. Guttman-Yassky E
  15. Beck LA
  16. Janes JM
  17. DeLozier AM
  18. Gamalo M
  19. Brinker DR
  20. Cardillo T
  21. Nunes FP
  22. Paller AS
  23. Wollenberg A
  24. Reich K
  Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials.; The British journal of dermatology. 2020 Jan 05.
• 1. Worm M
  2. Simpson EL
  3. Thaçi D
  4. Bissonnette R
  5. Lacour JP
  6. Beissert S
  7. Kawashima M
  8. Ferrándiz C
  9. Smith CH
  10. Beck LA
  11. Chan KC
  12. Chen Z
  13. Akinlade B
  14. Hultsch T
  15. Staudinger H
  16. Gadkari A
  17. Eckert L
  18. Davis JD
  19. Rajadhyaksha M
  20. Graham NMH
  21. Pirozzi G
  22. Stahl N
  23. Yancopoulos GD
  24. Ardeleanu M
  Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis: A Randomized Clinical Trial.; JAMA dermatology. 2019 Dec 26.
• 1. Moran MC
  2. Cahill MP
  3. Brewer MG
  4. Yoshida T
  5. Knowlden S
  6. Perez-Nazario N
  7. Schlievert PM
  8. Beck LA
  Staphylococcal Virulence Factors on the Skin of Atopic Dermatitis Patients.; mSphere; Vol 4(6). 2019 Dec 11.
• 1. Simpson EL
  2. Paller AS
  3. Siegfried EC
  4. Boguniewicz M
  5. Sher L
  6. Gooderham MJ
  7. Beck LA
  8. Guttman-Yassky E
  9. Pariser D
  10. Blauvelt A
  11. Weisman J
  12. Lockshin B
  13. Hultsch T
  14. Zhang Q
  15. Kamal MA
  16. Davis JD
  17. Akinlade B
  18. Staudinger H
  19. Hamilton JD
  20. Graham NMH
  21. Pirozzi G
  22. Gadkari A
  23. Eckert L
  24. Stahl N
  25. Yancopoulos GD
  26. Ruddy M
  27. Bansal A
  Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis: A Phase 3 Randomized Clinical Trial.; JAMA dermatology. 2019 Nov 06.
• 1. Alexander H
  2. Paller AS
  3. Traidl-Hoffmann C
  4. Beck LA
  5. De Benedetto A
  6. Dhar S
  7. Girolomoni G
  8. Irvine AD
  9. Spuls P
  10. Su J
  11. Thyssen JP
  12. Vestergaard C
  13. Werfel T
  14. Wollenberg A
  15. Deleuran M
  16. Flohr C
  The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group.; The British journal of dermatology. 2019 Nov 01.
• 1. Matson CC
  2. Beck LA
  3. Rajasekaran SK
  Using Language That Reflects Who Is the Center of Our Care.; Academic medicine : journal of the Association of American Medical Colleges; Vol 94(9). 2019 Sep.
• 1. Boorgula MP
  2. Taub MA
  3. Rafaels N
  4. Daya M
  5. Campbell M
  6. Chavan S
  7. Shetty A
  8. Cheadle C
  9. Barkataki S
  10. Fan J
  11. David G
  12. Beaty TH
  13. Ruczinski I
  14. Hanifin J
  15. Schneider LC
  16. Gallo RL
  17. Paller AS
  18. Beck LA
  19. Leung DY
  20. Mathias RA
  21. Barnes KC
  Replicated methylation changes associated with eczema herpeticum and allergic response.; Clinical epigenetics; Vol 11(1). 2019 Aug 23.
• 1. Brewer MG
  2. Yoshida T
  3. Kuo FI
  4. Fridy S
  5. Beck LA
  6. De Benedetto A
  Antagonistic Effects of IL-4 on IL-17A-Mediated Enhancement of Epidermal Tight Junction Function.; International journal of molecular sciences; Vol 20(17). 2019 Aug 21.
• 1. Wollenberg A
  2. Beck LA
  3. Blauvelt A
  4. Simpson EL
  5. Chen Z
  6. Chen Q
  7. Shumel B
  8. Khokhar FA
  9. Hultsch T
  10. Rizova E
  11. Rossi AB
  12. Graham NMH
  13. Pirozzi G
  14. Lu Y
  15. Ardeleanu M
  Laboratory safety of dupilumab in moderate-to-severe atopic dermatitis: results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS).; The British journal of dermatology. 2019 Aug 13.
• 1. Brewer MG
  2. Anderson EA
  3. Pandya RP
  4. De Benedetto A
  5. Yoshida T
  6. Hilimire TA
  7. Martinez-Sobrido L
  8. Beck LA
  9. Miller BL
  Peptides Derived from the Tight Junction Protein, Claudin-1, Disrupt Skin Barrier and Promote Responsiveness to an Epicutaneous Vaccine.; The Journal of investigative dermatology. 2019 Aug 02.
• 1. Deleuran M
  2. Thaçi D
  3. Beck LA
  4. de Bruin-Weller M
  5. Blauvelt A
  6. Forman S
  7. Bissonnette R
  8. Reich K
  9. Soong W
  10. Hussain I
  11. Foley P
  12. Hide M
  13. Bouaziz JD
  14. Gelfand JM
  15. Sher L
  16. Schuttelaar MLA
  17. Wang C
  18. Chen Z
  19. Akinlade B
  20. Gadkari A
  21. Eckert L
  22. Davis JD
  23. Rajadhyaksha M
  24. Staudinger H
  25. Graham NMH
  26. Pirozzi G
  27. Ardeleanu M
  Dupilumab shows long-term safety and efficacy in moderate-to-severe atopic dermatitis patients enrolled in a phase 3 open-label extension study.; Journal of the American Academy of Dermatology. 2019 Jul 30.
• 1. Johnson BB
  2. Beck LA
  3. Mustafa SS
  Remarkable response to dupilumab in a 5-year-old patient with severe, recalcitrant atopic dermatitis.; JAAD case reports; Vol 5(7). 2019 Jul.
• 1. Eichenfield LF
  2. Bieber T
  3. Beck LA
  4. Simpson EL
  5. Thaçi D
  6. de Bruin-Weller M
  7. Deleuran M
  8. Silverberg JI
  9. Ferrandiz C
  10. Fölster-Holst R
  11. Chen Z
  12. Graham NMH
  13. Pirozzi G
  14. Akinlade B
  15. Yancopoulos GD
  16. Ardeleanu M
  Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled Analysis.; American journal of clinical dermatology; Vol 20(3). 2019 Jun.
• 1. Calvert JS
  2. Grahn PJ
  3. Strommen JA
  4. Lavrov IA
  5. Beck LA
  6. Gill ML
  7. Linde MB
  8. Brown DA
  9. Van Straaten MG
  10. Veith DD
  11. Lopez C
  12. Sayenko DG
  13. Gerasimenko YP
  14. Edgerton VR
  15. Zhao KD
  16. Lee KH
  Electrophysiological Guidance of Epidural Electrode Array Implantation over the Human Lumbosacral Spinal Cord to Enable Motor Function after Chronic Paralysis.; Journal of neurotrauma; Vol 36(9). 2019 May 01.
• 1. Davidson WF
  2. Leung DYM
  3. Beck LA
  4. Berin CM
  5. Boguniewicz M
  6. Busse WW
  7. Chatila TA
  8. Geha RS
  9. Gern JE
  10. Guttman-Yassky E
  11. Irvine AD
  12. Kim BS
  13. Kong HH
  14. Lack G
  15. Nadeau KC
  16. Schwaninger J
  17. Simpson A
  18. Simpson EL
  19. Spergel JM
  20. Togias A
  21. Wahn U
  22. Wood RA
  23. Woodfolk JA
  24. Ziegler SF
  25. Plaut M
  Report from the National Institute of Allergy and Infectious Diseases workshop on "Atopic dermatitis and the atopic march: Mechanisms and interventions".; The Journal of allergy and clinical immunology; Vol 143(3). 2019 Mar.
• 1. Lebwohl M
  2. Alexis AF
  3. Beck LA
  4. Block JK
  5. Eichenfield LF
  6. Fonacier L
  7. Guttman-Yassky E
  8. Paller AS
  9. Pariser D
  10. Silverberg JI
  11. Boguniewicz M
  Systemic Therapies for Moderate-to-Severe Atopic Dermatitis: Expert Perspectives in Practice; Journal of drugs in dermatology : JDD; Vol 18(2). 2019 Feb 01.
• 1. Pietromonaco PR
  2. Beck LA
  Adult attachment and physical health.; Current opinion in psychology; Vol 25. 2019 Feb.
• 1. Soh JM
  2. Mercurio MG
  3. Beck LA
  Parental decisions for adolescent patients: Ethical considerations of information withholding.; Journal of the American Academy of Dermatology; Vol 80(1). 2019 Jan.
• 1. Shah PR
  2. Scott G
  3. Beck LA
  Image Gallery: Hairy-cell leukaemia presenting with Sweet syndrome.; The British journal of dermatology; Vol 180(1). 2019 Jan.
• 1. Johnson BB
  2. Franco AI
  3. Beck LA
  4. Prezzano JC
  Treatment-resistant atopic dermatitis: challenges and solutions.; Clinical, cosmetic and investigational dermatology; Vol 12. 2019.
• 1. Gill ML
  2. Grahn PJ
  3. Calvert JS
  4. Linde MB
  5. Lavrov IA
  6. Strommen JA
  7. Beck LA
  8. Sayenko DG
  9. Van Straaten MG
  10. Drubach DI
  11. Veith DD
  12. Thoreson AR
  13. Lopez C
  14. Gerasimenko YP
  15. Edgerton VR
  16. Lee KH
  17. Zhao KD
  Publisher Correction: Neuromodulation of lumbosacral spinal networks enables independent stepping after complete paraplegia.; Nature medicine; Vol 24(12). 2018 Dec.
• 1. Kwon CW
  2. Beck LA
  Severe atopic dermatitis: Therapeutic update.; Allergy and asthma proceedings; Vol 39(6). 2018 Nov 01.
• 1. Garlanger KL
  2. Beck LA
  3. Cheville AL
  Functional outcomes in patients with co-occurring traumatic brain injury and spinal cord injury from an inpatient rehabilitation facility's perspective.; The journal of spinal cord medicine; Vol 41(6). 2018 Nov.
• 1. An Y
  2. Adams JR
  3. Hollern DP
  4. Zhao A
  5. Chang SG
  6. Gams MS
  7. Chung PED
  8. He X
  9. Jangra R
  10. Shah JS
  11. Yang J
  12. Beck LA
  13. Raghuram N
  14. Kozma KJ
  15. Loch AJ
  16. Wang W
  17. Fan C
  18. Done SJ
  19. Zacksenhaus E
  20. Guidos CJ
  21. Perou CM
  22. Egan SE
  Cdh1 and Pik3ca Mutations Cooperate to Induce Immune-Related Invasive Lobular Carcinoma of the Breast.; Cell reports; Vol 25(3). 2018 Oct 16.
• 1. Pittelkow TP
  2. Bendel MA
  3. Lueders DR
  4. Beck LA
  5. Pingree MJ
  6. Hoelzer BC
  Title: Quantifying the change of spasticity after intrathecal baclofen administration: A descriptive retrospective analysis.; Clinical neurology and neurosurgery; Vol 171. 2018 Aug.
• 1. Ke X
  2. Kavati A
  3. Wertz D
  4. Huang Q
  5. Wang L
  6. Willey VJ
  7. Stephenson JJ
  8. Ortiz B
  9. Paknis B
  10. Bernstein JA
  11. Beck LA
  Real-World Characteristics and Treatment Patterns in Patients with Urticaria Initiating Omalizumab in the United States.; Journal of managed care & specialty pharmacy; Vol 24(7). 2018 Jul.
• 1. Weidinger S
  2. Beck LA
  3. Bieber T
  4. Kabashima K
  5. Irvine AD
  Atopic dermatitis.; Nature reviews. Disease primers; Vol 4(1). 2018 Jun 21.
• 1. Lipof JS
  2. Beck LA
  3. Reddy SC
  4. Southgate RD
  5. Carney-Young K
  6. Hammert WC
  Necrotizing Sweet Syndrome of the Upper Extremity After Elective Hand Surgery.; The Journal of hand surgery; Vol 43(4). 2018 Apr.
• 1. Simpson EL
  2. Villarreal M
  3. Jepson B
  4. Rafaels N
  5. David G
  6. Hanifin J
  7. Taylor P
  8. Boguniewicz M
  9. Yoshida T
  10. De Benedetto A
  11. Barnes KC
  12. Leung DYM
  13. Beck LA
  Atopic dermatitis Subjects Colonized with Staphylococcus aureus have a Distinct Phenotype and Endotype.; The Journal of investigative dermatology. 2018 Mar 28.
• 1. Wang L
  2. Ke X
  3. Kavati A
  4. Wertz D
  5. Huang Q
  6. Willey VJ
  7. Stephenson JJ
  8. Ortiz B
  9. Paknis B
  10. Bernstein JA
  11. Beck LA
  Real-world treatment patterns and outcomes of omalizumab use in patients with chronic idiopathic urticaria.; Current medical research and opinion; Vol 34(1). 2018 Jan.
• 1. Gill ML
  2. Grahn PJ
  3. Calvert JS
  4. Linde MB
  5. Lavrov IA
  6. Strommen JA
  7. Beck LA
  8. Sayenko DG
  9. Van Straaten MG
  10. Drubach DI
  11. Veith DD
  12. Thoreson AR
  13. Lopez C
  14. Gerasimenko YP
  15. Edgerton VR
  16. Lee KH
  17. Zhao KD
  Neuromodulation of lumbosacral spinal networks enables independent stepping after complete paraplegia.; Nature medicine; Vol 24(11). 2018 Jan.
• 1. Fingrut W
  2. Beck LA
  3. Lo D
  Building an oncology community of practice to improve cancer care.; Current oncology (Toronto, Ont.); Vol 25(6). 2018 Jan.
• 1. Fingrut W
  2. Beck LA
  3. Lo D
  Oncology communities of practice: insights from a qualitative analysis.; Current oncology (Toronto, Ont.); Vol 25(6). 2018 Jan.
• 1. Ke X
  2. Kavati A
  3. Wertz D
  4. Huang Q
  5. Wang L
  6. Willey VJ
  7. Stephenson JJ
  8. Ortiz B
  9. Paknis B
  10. Bernstein JA
  11. Beck LA
  Real-World Characteristics and Treatment Patterns in Patients with Urticaria Initiating Omalizumab in the United States.; Journal of managed care & specialty pharmacy. 2017 Dec 19.
• 1. Boguniewicz M
  2. Alexis AF
  3. Beck LA
  4. Block J
  5. Eichenfield LF
  6. Fonacier L
  7. Guttman-Yassky E
  8. Paller AS
  9. Pariser D
  10. Silverberg JI
  11. Lebwohl M
  Expert Perspectives on Management of Moderate-to-Severe Atopic Dermatitis: A Multidisciplinary Consensus Addressing Current and Emerging Therapies.; The journal of allergy and clinical immunology. In practice; Vol 5(6). 2017 Nov.
• 1. Finlay AY
  2. Kaplan AP
  3. Beck LA
  4. Antonova EN
  5. Balp MM
  6. Zazzali J
  7. Khalil S
  8. Maurer M
  Omalizumab substantially improves dermatology-related quality of life in patients with chronic spontaneous urticaria.; Journal of the European Academy of Dermatology and Venereology : JEADV; Vol 31(10). 2017 Oct.
• 1. Beck LA
  High Expectations.; The journal of spinal cord medicine; Vol 40(5). 2017 Sep.
• 1. Prezzano JC
  2. Beck LA
  Long-Term Treatment of Atopic Dermatitis.; Dermatologic clinics; Vol 35(3). 2017 Jul.